Ribavirin treatment for chronic hepatitis C
- 1 May 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 337 (8749), 1058-1061
- https://doi.org/10.1016/0140-6736(91)91707-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Molecular Mechanisms of Action of RibavirinClinical Infectious Diseases, 1990
- A Phase 1 Study of Ribavirin in Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDSThe Lancet, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Long‐term follow‐up of chronic post‐transfusion non‐A, non‐B hepatitis: clinical and histological outcomeLiver International, 1988
- Non-A, non-B Hepatitis after Open-heart Surgery in Stockholm: Declining Incidence after Introduction of Restrictions for Blood Donations due to the Human Immunodeficiency VirusScandinavian Journal of Infectious Diseases, 1987
- Evaluation of Ribavirin in the Treatment of Acute HepatitisChemotherapy, 1982